Related Experiment Video
Updated: May 12, 2026
07:45
Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery
Published on: March 4, 2021
Long-term course in type 2 idiopathic macular telangiectasia
Tobias Meyer-ter-Vehn1, Sina Herzog, Marc Schargus
1Department of Ophthalmology, University of Wuerzburg, Josef-Schneider-Str. 11, 97080, Wuerzburg, Germany, T.Meyer-ter-Vehn@augenklinik.uni-wuerzburg.de.
Summary
Idiopathic macular telangiectasia is a chronic condition causing vision loss over decades. Long-term studies show visual acuity declines slowly, with no significant difference between treatments like anti-VEGF or laser therapy.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Medical Research
Background:
- Idiopathic macular telangiectasia (IMT) is a progressive retinal disorder.
- Understanding its long-term progression is crucial for patient management.
Purpose of the Study:
- To investigate the long-term natural history of type 2 IMT.
- To evaluate the efficacy of anti-VEGF and laser treatments.
Main Methods:
- Retrospective case series of 19 patients (38 eyes) with symptomatic type 2 IMT.
- Treatments included intravitreal bevacizumab and focal laser.
- Follow-up involved visual acuity, angiography, and OCT for morphology and thickness.
Main Results:
- Mean follow-up was 81 months; visual acuity varied significantly.
- Visual acuity decreased by an average of 4.1 lines over 10 years.
- No significant difference in visual acuity was observed between treatment groups (no treatment, bevacizumab, laser) after 3 and 5 years.
Conclusions:
- Type 2 IMT is a chronic, slowly progressing disease causing retinal atrophy and vision impairment over decades.
- Long-term observational data is essential for assessing therapeutic strategies.
Related Concept Videos
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...